Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Prelude Therapeutics Inc | Chief Financial Officer | Employee Stock Option (Right to Buy) | 264K | Aug 25, 2021 | Direct | ||
Prelude Therapeutics Inc | Chief Financial Officer | Common Stock | 0 | $3.77 | Aug 25, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PRLD | Prelude Therapeutics Inc | Aug 25, 2021 | 5 | -$262K | 4 | Aug 27, 2021 | Chief Financial Officer |
PRLD | Prelude Therapeutics Inc | Jul 20, 2021 | 1 | $0 | 4 | Jul 22, 2021 | Chief Financial Officer |
PRLD | Prelude Therapeutics Inc | May 25, 2021 | 6 | -$270K | 4 | May 27, 2021 | Chief Financial Officer |